Rosenbauers, Profit

Rosenbauer's Profit Gain Masks a Deepening Cash Drain

Published on 11/17/2026 at 01:10 | Editorial boerse-global.de
Rosenbauer's nine-month EBIT rose to €42.4m but operating cash flow swung to ?€110.6m as working capital swelled; NuWays reiterated buy.
Rosenbauer's Profit Gain Masks a Deepening Cash Drain Illustration mit AI erstellt.

Rosenbauer closed Friday's session down 4.4% after a set of nine-month figures that showed earnings moving in one direction and liquidity in the other. The Austrian firefighting-vehicle maker booked an operating cash outflow of ?110.6 million euros, a sharp reversal from the positive 2.0 million euros recorded a year earlier.

The swing came as net working capital swelled to 654.2 million euros, tying up funds that the income statement never captures. Revenue for the first nine months of 2026 advanced 2.9% to 978.6 million euros, while EBIT climbed to 42.4 million euros from 33.4 million euros in the prior-year period. Net profit for the period reached 16.6 million euros.

Orders, though, headed the other way. Incoming business slipped to 1.1 billion euros from 1.16 billion euros, a decline that sits awkwardly beside the improved top line.

A Bullish Call That Acknowledges the Miss

NuWays reaffirmed its buy rating and 71-euro price target on Monday, even as it flagged weaker third-quarter revenue and EBIT. The broker also pointed to two headwinds beyond the company's control: the Middle East conflict and the rollout of SAP S/4HANA.

Should investors sell immediately? Or is it worth buying Rosenbauer?

Baader Bank took a sharper view of management's refined guidance. The precise 2026 outlook, it said Friday, implies roughly 10% downside to consensus EBIT expectations. Rosenbauer's board is targeting about 1.55 billion euros in revenue and some 90 million euros in EBIT for the full year.

Management has made process stabilization and on-time deliveries its top priorities in the wake of the SAP migration. Whether those efforts translate into a firmer financial picture is the question investors now have to weigh — a buy recommendation on its own does not settle it.

Where the Thesis Could Hold

The constructive reading rests on execution. If workflows settle down after the ERP switch and delivery punctuality improves, the operating trend could become more dependable. A simultaneous release of working-capital pressure would give those gains real financial backing.

What would make such a recovery convincing is not simply higher earnings but a narrower gap between profit and cash generation. So far the two have diverged, and an EBIT improvement that arrives without relief on capital tied up in the business would carry less weight.

What Could Go Wrong

The bear case starts where stabilization drags on or deliveries fall short of the company's own targets. In that scenario, financial relief would also be delayed, and a persistently high funding need would dilute the significance of positive EBIT figures.

Rosenbauer at a turning point? This analysis reveals what investors need to know now.

Public investment budgets, along with trade and geopolitical developments, are the uncertainties Rosenbauer itself cites. Those forces cap what internal fixes alone can achieve: even smoothly stabilized operations would not neutralize external risk. The genuine counterargument therefore has two layers — the company must repair its own processes while navigating an unsettled environment, and progress on one front offers no automatic protection on the other.

The April Test

The next scheduled disclosure is 15 April 2027, when full-year 2026 results are due. How management explains the trajectory of net working capital and operating cash flow will matter more than the direction of any single earnings line. A credible turnaround would need to show not just profits but a closing of the distance between earnings and liquidity.

Ad

Rosenbauer Stock: New Analysis - 17 November

Fresh Rosenbauer information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rosenbauer analysis...

Disclaimer...
en | AT0000922554 | ROSENBAUERS | boerse | 70523221 |